Physician profile
Ryan C Ollerton
NPI 1528275898
$4,550.71
in general payments reported to CMS, 2019-2025
21 companies · $3,828 in 2025
The $3,828 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.79 · 2020: $68.86 · 2021: $256 · 2022: $175 · 2023: $130 · 2024: $46.77 · 2025: $3,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $786 · Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $786.43 |
| Food and Beverage | $218.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,870.03 | 2023-2025 | Da Vinci Surgical System |
| Channel Medsystems, INC. | $119.94 | 2022 | |
| Therapeuticsmd, INC. | $78.22 | 2019-2021 | |
| Evofem Biosciences, INC. | $61.89 | 2021-2022 | |
| Hologic Sales and Service, LLC | $45.96 | 2019-2024 | Novasure, Myosure Tissue Removal Device |
| Biogen, INC. | $40.81 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $40.13 | 2020-2021 | |
| Abbvie INC. | $36.53 | 2021-2023 | |
| Exeltis, USA INC. | $32.96 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.91 | 2020-2021 | |
| Boston Scientific Corporation | $27.84 | 2021 | |
| Dysis Medical, INC. | $26.82 | 2021 | |
| Pfizer INC. | $20.56 | 2023 | |
| Teleflex LLC | $19.25 | 2019 | |
| Becton, Dickinson and Company | $18.12 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $17.63 | 2023 | |
| Axonics, INC. | $15.22 | 2024 | Bulkamid |
| Takeda Pharmaceuticals U.S.A., INC. | $12.98 | 2021 | |
| Ethicon US, LLC | $12.57 | 2021 | |
| Organon LLC | $11.67 | 2021 | |
| Merck Sharp & Dohme LLC | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Ollerton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.